1 Min Read
April 28 (Reuters) - Novartis AG:
* Says U.S. wholesale acquisition cost of Rydapt for AML indication is $7,495 for 14-day package and $14,990 for 28-day package - spokeswoman Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.